Immediate Impact
8 from Science/Nature 63 standout
Citing Papers
Glioblastoma Therapy: Past, Present and Future
2024 Standout
Late-stage Functionalization for Improving Drug-like Molecular Properties
2023 Standout
Works of Alex McCormick being referenced
Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial
2020
Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitor11CRESTOR is a trademark, the property of AstraZeneca PLC. Research discussed in this article was supported by AstraZeneca.
2001
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Alex McCormick | 281 | 94 | 255 | 218 | 17 | 735 | |
| S. Unger | 251 | 138 | 134 | 179 | 19 | 708 | |
| Georgina Meneses‐Lorente | 259 | 119 | 339 | 107 | 51 | 837 | |
| Helen Ambrose | 217 | 86 | 143 | 230 | 21 | 597 | |
| Katrijn Bogman | 313 | 130 | 191 | 98 | 18 | 715 | |
| Shazia Ali | 212 | 163 | 251 | 201 | 14 | 738 | |
| Raju D. Amin | 106 | 165 | 125 | 259 | 15 | 783 | |
| Suman Lal | 263 | 157 | 184 | 203 | 25 | 841 | |
| Iwao Yamada | 212 | 92 | 228 | 131 | 17 | 668 | |
| P. Kellie Turner | 370 | 55 | 156 | 123 | 43 | 787 | |
| Maureen Boxer | 100 | 113 | 240 | 108 | 14 | 616 |
All Works
Login with ORCID to disown or claim papers
Loading papers...